Antihypertensive drug class interactions and risk for incident diabetes: A nested case-control study

Journal of the American Heart Association

Volumn 2, Issue 3, 2013, Pages

  Cooper DeHoff, Rhonda M ^a,b,c   Bird, Steven T ^a,c   Nichols, Gregory A ^d   Delaney, Joseph A ^a,e   Winterstein, Almut G ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Blockers; Diabetes; Diabetogenic; Drug interactions; Hypertension; RAS blockers; Thiazide diuretics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; ATYPICAL ANTIPSYCHOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; GLUCOSE; HYDROCORTISONE; METHYLPREDNISOLONE; MEVINOLIN; NORADRENALIN UPTAKE INHIBITOR; PRAVASTATIN; PREDNISOLONE; PREDNISONE; ROSUVASTATIN; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; THIAZIDE DIURETIC AGENT; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; Β BLOCKERS; CHEMICALLY INDUCED DISORDER; DIABETOGENIC; DRUG INTERACTION; MIDDLE AGED; RAS BLOCKERS; RISK FACTOR; THIAZIDE DIURETICS; CHEMICALLY INDUCED;

Β BLOCKERS; DIABETES; DIABETOGENIC; DRUG INTERACTIONS; HYPERTENSION; RAS BLOCKERS; THIAZIDE DIURETICS;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DIABETES MELLITUS; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84891382171     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.113.000125     Document Type: Article

References (27)

1. Economic costs of diabetes in the U.S. in 2007 Diabetes Care. 2008;31:596- 615.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
3. Keenan NL, Rosendorf KA; Centers for Disease Control and Prevention. Prevalence of hypertension and controlled hypertension-United States, 2005-2008. MMWR Surveill Summ. 2011;60(suppl): 94-97
4. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150:640-644, 644.e641.
5. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599-606. American College of Cardiology Foundation. Published by Elsevier Inc; 2012.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217- 223.
7. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
9. 2010 Top 200 Generic Drugs by Total Prescriptions: 2011. http://drugtopics. modernmedicine.com/. Accessed June 2, 2013.
10. 2010 Top 200 Brand Drugs by Total Prescription: 2011. http://drugtopics. modernmedicine.com/. Accessed June 2, 2013.
11. Bangalore S, Parkar S, Grossman E, Messerli FH. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol. 2007;100:1254-1262.
12. Taylor EN, Hu FB, Curhan GC. Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care. 2006;29:1065-1070.
13. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201-207.
14. Kit BK, Ogden CL, Flegal KM. Prescription medication use among normal weight, overweight, and obese adults, united states, 2005-2008. Ann Epidemiol. 2012;22:112-119.
15. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med. 2008;121:519-524.
16. Association AD. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
17. Cooper-DeHoff RM, Wen S, Beitelshees AL, Zineh I, Gums JG, Turner ST, Gong Y, Hall K, Parekh V, Chapman AB, Boerwinkle E, Johnson JA. Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications. Hypertension. 2010;55:61- 68.
18. Lind L, Pollare T, Berne C, Lithell H. Long-term metabolic effects of antihypertensive drugs. Am Heart J. 1994;128:1177-1183.
19. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol. 2012;19:585-667.
20. Investigators DT, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006; 355:1551-1562.
21. Group NS, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamas G, Tognoni G, Tuomilehto J, Villamil AS, Vozar J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362:1477-1490.
22. Fradkin JE, Roberts BT, Rodgers GP. What's preventing US from preventing type 2 diabetes? N Engl J Med. 2012;367:1177-1179.
23. Chatterjee R, Narayan KM, Lipscomb J, Jackson SL, Long Q, Zhu M, Phillips LS. Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care. 2013; Feb 7 [Epub ahead of print] doi: 10.2337/ dc12-1752.
24. Karnes JH, Cooper-DeHoff RM. Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects. Expert Rev Cardiovasc Ther. 2009;7:689-702.
25. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981-2997.
26. Barzilay JI, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Black HR, Cushman WC, Ford CE, Margolis KL, Moloo J, Oparil S, Piller LB, Simmons DL, Sweeney ME, Whelton PK, Wong ND, Wright JT, Group ACR. Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT diabetes extension study. Circ Cardiovasc Qual Outcomes. 2012;5:153-162.
27. Ali M, Bullard K, Imperatore G, Barker L, Gregg E. Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes-National Health and Nutrition Examination Survey, United States, 2007-2010. Morb Mortal Wkly Rep. 2012;61:32-37.